Pelthos Therapeutics Inc.
PTHS
$36.31
$1.564.49%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 164.95% | 121.73% | |||
| Gross Profit | -164.95% | -121.73% | |||
| SG&A Expenses | 65.62% | 6.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 76.14% | 0.49% | |||
| Operating Income | -76.14% | -0.49% | |||
| Income Before Tax | -75.28% | -2.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -75.28% | -2.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -75.28% | -2.12% | |||
| EBIT | -76.14% | -0.49% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -67.70% | -0.60% | |||
| Normalized Basic EPS | -67.70% | -0.60% | |||
| EPS Diluted | -67.70% | -0.60% | |||
| Normalized Diluted EPS | -67.70% | -0.60% | |||
| Average Basic Shares Outstanding | 4.52% | 1.51% | |||
| Average Diluted Shares Outstanding | 4.52% | 1.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||